Isabel Dorronsoro Díaz

Title: Isabel Dorronsoro Díaz: Innovator in GSK-3 Inhibitors

Introduction

Isabel Dorronsoro Díaz is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective GSK-3 inhibitors. Her work is crucial for addressing various diseases, including Alzheimer's disease and type II diabetes.

Latest Patents

Isabel holds a patent for GSK-3 inhibitors, specifically for thiadiazolidine compounds of formula I. These compounds feature an organic group with at least eight atoms selected from carbon or oxygen, which is not directly linked to nitrogen through a carbonyl group. The compounds also include at least one aromatic ring and are designed to improve bioavailability. They are particularly useful in treating GSK-3 mediated diseases, such as Alzheimer's disease, type II diabetes, depression, and brain injury. Isabel has 1 patent to her name.

Career Highlights

Isabel is currently associated with Noscira, S.A., where she continues her innovative work in pharmaceutical research. Her expertise in GSK-3 inhibitors has positioned her as a key figure in the development of new therapeutic options.

Collaborations

Isabel has collaborated with notable colleagues, including Miguel Medina Padilla and Mercedes Alonso Cascón. These partnerships have enhanced her research and contributed to the advancement of her projects.

Conclusion

Isabel Dorronsoro Díaz is a trailblazer in the field of pharmaceutical innovation, particularly in the development of GSK-3 inhibitors. Her work holds promise for the treatment of several critical health conditions, showcasing her impact on medical science.